Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Patented Inventions Double at UB: Scientist-entrepreneurs are honored at Inventors Reception

Abstract:
An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins.

Patented Inventions Double at UB: Scientist-entrepreneurs are honored at Inventors Reception

Buffalo, NY | Posted on March 5th, 2009

No, they're not the stuff of science fiction.

These are some of the new inventions that were patented in 2008 by University at Buffalo researchers, a year that has seen the number of UB patents more than double from nine in 2007 to 21 last year.

More than 40 of these UB researchers were honored for their efforts to bring their research out of the lab and into the marketplace at the UB Inventors and Entrepreneurs Reception held March 5 in the Center for Tomorrow on the UB North (Amherst) Campus.

The reception also honored 11 UB technologies that were licensed to industry and the three most recent "graduates" of UB's Technology Incubator.

"The jump we saw this year in our patent activity is a testament to the intense and growing commitment we are seeing among our scientist-entrepreneurs, who increasingly seek ways to get their scientific advances out into society," said Robert J. Genco, vice provost and director of the UB Office of Science, Technology Transfer and Economic Outreach (STOR), which co-sponsored the event with the UB Office of the Vice President for Research.

"They know that the most important scientific discovery in the world may provide little value to society if it goes no further than a journal publication," he continued. "Today, UB is honoring its professors who have taken the critical steps toward using their scientific and technological expertise to address some of the world's most profound problems."

Genco and Kenneth M. Tramposch, associate vice president for research, addressed the inventors. President John B.Simpson and Provost Satish K. Tripathi also congratulated the inventors.

Some of the newly patented inventions are:

-- An antibody with the potential to stop breast cancer metastasis. "The monoclonal antibody we developed has been shown to extend significantly the survival of mice with human breast-cancer tumors and to inhibit the cancer's spread to the lungs in the animals by more than 50 percent," said lead investigator Kate Rittenhouse-Olson, Ph.D., associate professor of clinical and laboratory sciences in the UB School of Medicine and Biomedical Sciences.

-- The nanoparticle that treats hemophiliac patients who develop resistance to Factor VIII. "Our multifunctional, lipid nanoparticle improves the safety and efficacy of the protein by multiple mechanisms, improving stability of the protein, altering the immune response and making the particle stay in the blood longer," said lead investigator Sathy Balu-Iyer, Pharm.D., associate professor of pharmaceutical sciences in the UB School of Pharmacy and Pharmaceutical Sciences.

-- A quantum dot with the potential to treat cancer or harness solar energy. "Our process for synthesizing these silicon nanoparticles makes them potentially useful for various applications, including biological imaging and diagnostics, solar cells and light-emitting diodes," said Mark T. Swihart, UB associate professor of chemical and biological engineering in the School of Engineering and Applied Sciences and lead investigator.

-- An air sterilizer that kills every biological agent it meets. "The BioBlower can rapidly and continuously kill airborne biological pathogens, such as anthrax, and it has demonstrated the ability to eradicate other airborne pathogens, such as avian flu, SARS and influenza viruses," said James F. Garvey, Ph.D., UB professor of chemistry in the College of Arts and Sciences and lead investigator.

Also presented at the reception was the 2008 UB Entrepreneurial Spirit Award recognizing researchers who founded a company to license a UB technology. This year, it was presented to Bradley P. Fuhrman, M.D., professor of pediatrics and anesthesiology in the UB School of Medicine and Biomedical Sciences and chief of critical care at Women & Children's Hospital of Buffalo, and Mark Dowhy, director of the Pediatric Critical Care Laboratory in the UB Department of Pediatrics.

The invention was licensed from UB to Medical Conservation Devices (MCD) of Buffalo, located in UB's New York State Center of Excellence in Bioinformatics and Life Sciences. Fuhrman and Dowhy are founding partners in MCD, which is raising funds to further develop the prototype for FDA medical-device evaluation.

The event also will honor the three "graduates" of the UB Technology Incubator, which have now expanded into their own space. They are:

-- Absolute Energy, moving to Grand Island, a complete Energy Management Services and IT sourcing partner;

-- Lynx Technologies, moving to Grand Island, provides companies managing large networking computing environments with high-availability, high-reliability systems;

-- Integral Information Systems, moving to Buffalo, a developer of advanced analytical software and decision support systems for health care providers.

####

About University at Buffalo
The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.

For more information, please click here

Contacts:
Ellen Goldbaum

716-645-5000 ext 1415

Copyright © University at Buffalo

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Academic/Education

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

University of Waterloo Visits China to Strengthen Bonds With Research Partners April 21st, 2014

Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014

First annual science week highlights STEM pipeline and partnerships: UB, SUNY Buffalo State and ECC team up with the City of Buffalo and its schools for April 7-11 events April 3rd, 2014

Nanomedicine

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Amino-functionalized carbon nanotubes act as a carrier for nerve growth factor April 21st, 2014

Newly-Produced Bone Cement Able to Carry Medicine April 21st, 2014

Announcements

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

Events/Classes

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

Quantum Dots/Rods

Shiny quantum dots brighten future of solar cells: Photovoltaic solar-panel windows could be next for your house April 14th, 2014

Nanotech Business Review 2013-2014 April 9th, 2014

'Quantum Dots Market by Product (QD Displays, Lasers, Medical Devices, Solar Cells, Chip, Sensor), Application (Healthcare, Optoelectronics, Sustainable Energy), Material (Cadmium Selenide, Sulfide, Telluride), and Geography - Forecast & Analysis (2013 - 2020)' March 31st, 2014

Quantum Dots Take Center Stage at Inaugural Event: QD Vision Co-Founder and CTO Dr. Seth Coe-Sullivan to Chair First Quantum Dots Forum, March 26, 2014, San Diego, CA March 25th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE